Logo image of CIA

CITIZENS INC (CIA) Stock Fundamental Analysis

NYSE:CIA - New York Stock Exchange, Inc. - US1747401008 - Common Stock - Currency: USD

4.29  -0.22 (-4.88%)

After market: 4.29 0 (0%)

Fundamental Rating

2

Taking everything into account, CIA scores 2 out of 10 in our fundamental rating. CIA was compared to 143 industry peers in the Insurance industry. CIA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CIA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CIA had positive earnings in the past year.
In the past year CIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CIA reported negative net income in multiple years.
In the past 5 years CIA always reported a positive cash flow from operatings.
CIA Yearly Net Income VS EBIT VS OCF VS FCFCIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

CIA's Return On Assets of 0.88% is on the low side compared to the rest of the industry. CIA is outperformed by 62.94% of its industry peers.
The Return On Equity of CIA (7.09%) is worse than 63.64% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.74%, CIA is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
ROA 0.88%
ROE 7.09%
ROIC 0.74%
ROA(3y)0.64%
ROA(5y)0.66%
ROE(3y)5.37%
ROE(5y)4.79%
ROIC(3y)N/A
ROIC(5y)N/A
CIA Yearly ROA, ROE, ROICCIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CIA's Profit Margin of 6.09% is in line compared to the rest of the industry. CIA outperforms 43.36% of its industry peers.
CIA's Profit Margin has declined in the last couple of years.
CIA's Operating Margin of 6.11% is on the low side compared to the rest of the industry. CIA is outperformed by 66.43% of its industry peers.
CIA's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.11%
PM (TTM) 6.09%
GM N/A
OM growth 3Y37.44%
OM growth 5Y21.86%
PM growth 3Y-25.45%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIA Yearly Profit, Operating, Gross MarginsCIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

More info and screens

4

2. Health

2.1 Basic Checks

CIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CIA has been increased compared to 1 year ago.
CIA has less shares outstanding than it did 5 years ago.
CIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CIA Yearly Shares OutstandingCIA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CIA Yearly Total Debt VS Total AssetsCIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

There is no outstanding debt for CIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.08
WACC8.87%
CIA Yearly LT Debt VS Equity VS FCFCIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CIA Yearly Current Assets VS Current LiabilitesCIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

CIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
The Revenue has been growing slightly by 1.80% in the past year.
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.71%
Revenue 1Y (TTM)1.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIA Yearly Revenue VS EstimatesCIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CIA Yearly EPS VS EstimatesCIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.1 0.2 0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.75, CIA can be considered very expensive at the moment.
CIA's Price/Earnings ratio is rather expensive when compared to the industry. CIA is more expensive than 80.42% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.98. CIA is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 35.75
Fwd PE N/A
CIA Price Earnings VS Forward Price EarningsCIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CIA is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CIA indicates a somewhat cheap valuation: CIA is cheaper than 62.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.85
EV/EBITDA 12.09
CIA Per share dataCIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CIA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CITIZENS INC

NYSE:CIA (4/29/2025, 7:56:44 PM)

After market: 4.29 0 (0%)

4.29

-0.22 (-4.88%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-07 2025-05-07
Inst Owners17.11%
Inst Owner Change0.23%
Ins Owners1.51%
Ins Owner Change4.79%
Market Cap214.11M
Analysts84
Price Target5.61 (30.77%)
Short Float %10.95%
Short Ratio42.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.58%
Min EPS beat(2)-38.12%
Max EPS beat(2)-27.05%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-2.27%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.32%
PT rev (3m)7.32%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)-11.59%
EPS NY rev (3m)-19.74%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 35.75
Fwd PE N/A
P/S 0.87
P/FCF 6.85
P/OCF 6.71
P/B 1.02
P/tB 1.07
EV/EBITDA 12.09
EPS(TTM)0.12
EY2.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY14.6%
OCF(TTM)0.64
OCFY14.91%
SpS4.91
BVpS4.21
TBVpS4.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.88%
ROE 7.09%
ROCE 0.94%
ROIC 0.74%
ROICexc 0.75%
ROICexgc 0.77%
OM 6.11%
PM (TTM) 6.09%
GM N/A
FCFM 12.76%
ROA(3y)0.64%
ROA(5y)0.66%
ROE(3y)5.37%
ROE(5y)4.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y41.5%
ROICexcg growth 5Y21.27%
ROICexc growth 3Y41.24%
ROICexc growth 5Y21.4%
OM growth 3Y37.44%
OM growth 5Y21.86%
PM growth 3Y-25.45%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 54.52%
Cap/Sales 0.27%
Interest Coverage 250
Cash Conversion 197.07%
Profit Quality 209.6%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC8.87%
ROIC/WACC0.08
Cap/Depr(3y)33.56%
Cap/Depr(5y)30.08%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.77%
EBIT growth 3Y36.42%
EBIT growth 5Y21.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.61%
FCF growth 3Y-7.51%
FCF growth 5Y-15.3%
OCF growth 1Y44.71%
OCF growth 3Y-7.63%
OCF growth 5Y-15.06%